Frequently Asked Questions
(FAQs)

Veeda Lifesciences Logo

1

We have reimagined who we are to better serve our clients and create even greater possibilities. The new identity, Veeda Lifesciences, marks our transition from generics to innovation, from local to global, and from small molecules to biologics.

 

This rebranding reflects our commitment to delivering integrated services across the entire lifecycle of drug development—from discovery to clinical phases.

 

We are embracing a borderless approach to offer faster, more innovative solutions, ensuring exceptional quality and diversity in clinical trials globally.

 

This evolution allows us to meet the growing needs of the industry and bring our clients cutting-edge services with speed and efficiency.

2

  • New Brand Identity: Veeda Clinical Research and Heads will fully transition to the “Veeda Lifesciences” brand, with updates to the logo, tagline, key messaging, including vision and mission statements, and overall branding. Bioneeds will adopt the new tagline and messaging, transitioning to “Bioneeds, a Veeda Lifesciences company” to align with our refreshed brand identity.
  • Website: The websites for Veeda Clinical Research and Heads will merge into a unified platform at www.veedalifesciences.com.
  • Email Addresses: All employees of Veeda Clinical Research & Heads will transition to @veedalifesciences.com email addresses starting in the first week of January 2025. This will occur in phases.
  • Updated Communication Materials: All marketing materials, including presentations, business cards, email signatures, and signage, will reflect the new brand identity.

3

  • Legal Entity Name: The legal entities will remain the same.
  • Services Offered: Our full range of services—from preclinical to late-phase clinical trial execution—remains unchanged.
  • Core Documents: Legal and non-legal documents will only be updated to reflect the new branding (logo, email, website as applicable), with no changes to the content and legal entity.

4

The new branding will officially take effect in the first week of January 2025.

5

Bioneeds is currently in Phase 1 of its rebranding, transitioning to “Bioneeds, a Veeda Lifesciences company,” with a new logo, tagline, and messaging.

 

Phase 2 will involve additional updates and full integration into the new brand identity.

6

You will notice updates across all official communication channels:

  • Website: Our new website is www.veedalifesciences.com.
  • Email Address: Our new official email address is Info@veedalifesciences.com.
  • Updated Branding: Expect all communications—marketing materials, presentations, and official documents—to reflect the new Veeda Lifesciences branding.

7

Yes, you will still be able to reach your point of contact through their old email address for a period of time.

 

However, we recommend transitioning to the new @veedalifesciences.com email addresses, as advised by your point of contact, for all future communications.

8

No, the rebranding does not change the core of our services, but it reflects our growth and evolution. We now offer an expanded range of services, building on our expertise in both generics and novel drug development.

 

Our rebranding showcases our broader capabilities as an integrated global service provider, ensuring we deliver exceptional support across the entire drug development continuum.

9

You can reach us through the new email Info@veedalifesciences.com, and our website will be accessible at www.veedalifesciences.com.